OOIR: Observatory of International Research

Papers

(The H4-Index of Cephalalgia is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
A missing piece in the puzzle of chronic dizziness: Dysautonomia	136
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	134
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	115
Harassment in the headache field: a global web-based cross-sectional survey	109
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	83
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy	73
Persistent idiopathic facial pain: Integrating headache neurology insights into interdisciplinary guidelines	63
Predictive value of preoperative white and gray matter microstructural alterations for microvascular decompression outcome in classical trigeminal neuralgia	56
Impaired bone status in high frequency episodic or chronic migraine women: A case-control study with blood and densitometric parameters	55
International Classification of Headache Disorders-4 – Work in Progress 1	54
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	52
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	50
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia	49
Evidence-based guidelines for the pharmacological treatment of migraine	49
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	48
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	48
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	47
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	46
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	45
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	43
IHC 2025 late-breaking abstracts	43
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	43
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	40
Systemic lupus erythematosus mimicking retinal migraine: a case report	40
A 7-year retrospective analysis of the management of children with acute headache presenting in a pediatric emergency department	38

Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	37
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	37
2025 Highlights in migraine prevention	35
An altered reward system characterizes chronic migraine with medication overuse headache	34
Depression screening in migraine - A double-edged sword	33
Rethinking Burning Mouth Syndrome: Toward a multidimensional classification of oral dysaesthetic and perceptual disorders in ICHD-4	31